CERS(Cerus Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $159.52M | $188.31M | $186.80M | $201.32M | $233.80M |
| 毛利润 | — | — | — | — | — |
| 营业利润 | −$48.94M | −$34.08M | −$30.05M | −$14.22M | −$8.68M |
| 净利润 | −$54.37M | −$42.78M | −$37.49M | −$20.92M | −$15.63M |
| 经营现金流 | −$33.92M | −$25.61M | −$43.17M | $11.36M | $4.84M |
| 自由现金流 | −$34.83M | −$27.61M | −$47.77M | $8.52M | $1.11M |
| 摊薄每股收益 | $-0.32 | $-0.24 | $-0.21 | $-0.11 | $-0.08 |